TK-254RX

TK-254RX · Teikoku Seiyaku Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TK-254RX, covering 2025-03-11 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Adhesion of TK-254RX on Healthy Participants [Phase 1]